This trial is testing whether a new imaging technique can help optimize tamoxifen dosing for breast cancer patients with a certain type of genetic mutation.
1 Primary · 6 Secondary · Reporting Duration: up to 6 months
Experimental Treatment
12 Total Participants · 1 Treatment Group
Primary Treatment: Tamoxifen · No Placebo Group · Phase < 1
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: